A cure for migraines? New drug gets EU approval

NHS to consider offering preventative injections which cut migraine rate by half

migraine genetic

The first licensed drug proven to be effective in preventing migraines may soon be available in the UK, after EU regulators gave it the green light.

The European Medicines Agency has approved Erenumab, specifically designed to prevent the onset of migraines, opening the door for the treatment to be made available on the NHS.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us